Description
CFXOTIL-CV DUO — A Broad-Spectrum Combination Built for Faster Recovery
CFXOTIL-CV DUO brings together Cefpodoxime Proxetil 100 mg and Clavulanic Acid 62.5 mg, a dual-action antibiotic combination designed to counter beta-lactamase producing organisms while extending broad-spectrum coverage against common bacterial infections. This pairing helps physicians address resistant strains more effectively than cefpodoxime alone, which is why combination antibiotics of this kind remain a steady prescription choice across general practice, ENT and respiratory care settings, making it a practical franchise addition in the anti-infective segment.
Quality Standards Franchise Partners Can Rely On
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company based in Panchkula, Haryana with manufacturing operations at our Baddi, Himachal Pradesh facility. CFXOTIL-CV DUO is produced under monitored quality protocols to ensure formulation stability and consistent therapeutic performance across every batch. For franchise partners, this translates into fewer supply-related concerns and stronger long-term credibility with doctors and chemists who prescribe antibiotics regularly. As a PCD pharma franchise company in India, we focus on building this kind of dependable, quality-first partnership with our associates.
Product Highlights for Franchise Partners
- Composition: Cefpodoxime Proxetil 100 mg + Clavulanic Acid 62.5 mg
- Dosage Form: Tablets
- Pack Size: 10x1x10
- Pack Type: Bottle (Glass) for enhanced product protection and durability
- Key Benefit: Broad-spectrum dual protection supporting faster clinical recovery
- Suited For: Distributors and medical representatives strengthening their anti-infective range
Franchise partners looking to expand into the antibiotic segment can explore this and other formulations through our PCD pharma franchise division, with complete promotional and documentation support for field operations.
Disclaimer: This is a prescription antibiotic and should be used strictly under the guidance of a registered medical practitioner.
